Literature DB >> 31431460

MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1.

Huai-Chia Chuang1, Chih-Chi Chang1, Chiao-Fang Teng1, Chia-Hsin Hsueh1, Li-Li Chiu1, Pu-Ming Hsu1, Ming-Ching Lee2, Chung-Ping Hsu2, Yi-Rong Chen3, Yi-Chung Liu4, Ping-Chiang Lyu5, Tse-Hua Tan6,7.   

Abstract

Overexpression of the serine/threonine kinase GLK/MAP4K3 in human lung cancer is associated with poor prognosis and recurrence, however, the role of GLK in cancer recurrence remains unclear. Here, we report that transgenic GLK promotes tumor metastasis and cell migration through the scaffold protein IQ motif-containing GTPase-activating protein 1(IQGAP1). GLK transgenic mice displayed enhanced distant metastasis. IQGAP1 was identified as a GLK-interacting protein; two proline-rich regions of GLK and the WW domain of IQGAP1 mediated this interaction. GLK and IQGAP1 colocalized at the leading edge including filopodia and lamellipodia of migrating cells. GLK directly phosphorylated IQGAP1 at Ser-480 enhancing Cdc42 activation and subsequent cell migration. GLK-induced cell migration and lung cancer metastasis were abolished by IQGAP1 depletion. Consistently, human NSCLC patient tissues displayed increased phospho-IQGAP1, which correlated with poor survival. Collectively, GLK promotes lung cancer metastasis by binding to, phosphorylating, and activating IQGAP1. SIGNIFICANCE: These findings show the critical role of the GLK-IQGAP cascade in cell migration and tumor metastasis, suggesting it as a potential biomarker and therapeutic target for lung cancer recurrence. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31431460     DOI: 10.1158/0008-5472.CAN-19-1402

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.

Authors:  BaiHeTiYa AZhaTi; Gaoliang Wu; Hailun Zhan; Wei Liang; Zhijian Song; Leilei Lu; Qichao Xie
Journal:  World J Surg Oncol       Date:  2022-07-12       Impact factor: 3.253

Review 2.  Role of IQGAP1 in Carcinogenesis.

Authors:  Tao Wei; Paul F Lambert
Journal:  Cancers (Basel)       Date:  2021-08-04       Impact factor: 6.575

3.  Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.

Authors:  Jie Yan; Daihong Wan
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

4.  MiR-409-3p targets a MAP4K3-ZEB1-PLGF signaling axis and controls brown adipose tissue angiogenesis and insulin resistance.

Authors:  Dakota Becker-Greene; Hao Li; Daniel Perez-Cremades; Winona Wu; Furkan Bestepe; Denizhan Ozdemir; Carolyn E Niosi; Ceren Aydogan; Dennis P Orgill; Mark W Feinberg; Basak Icli
Journal:  Cell Mol Life Sci       Date:  2021-10-26       Impact factor: 9.261

5.  Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis.

Authors:  Yuyan Fan; Hongyu Fan; Ping Li; Qingshan Liu; Lixia Huang; Yilun Zhou
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  An approach using Caenorhabditis elegans screening novel targets to suppress tumour cell proliferation.

Authors:  Yu-Qin Mao; San-Feng Han; Shi-Long Zhang; Zheng-Yan Zhang; Chao-Yue Kong; Hui-Ling Chen; Zhan-Ming Li; Pei-Ran Cai; Bing Han; Li-Shun Wang
Journal:  Cell Prolif       Date:  2020-05-25       Impact factor: 6.831

7.  The Correct Localization of Borealin in Midbody during Cytokinesis Depends on IQGAP1.

Authors:  Reziya Wumaier; Abudunaibi Aili; Hexige Saiyin; Pingzhao Zhang; Lihuan Cao; Aikeremujiang Muheremu
Journal:  Biomed Res Int       Date:  2020-06-24       Impact factor: 3.411

Review 8.  MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

Review 9.  MAP4K3/GLK in autoimmune disease, cancer and aging.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  J Biomed Sci       Date:  2019-10-22       Impact factor: 8.410

10.  MAP4K3/GLK inhibits Treg differentiation by direct phosphorylating IKKβ and inducing IKKβ-mediated FoxO1 nuclear export and Foxp3 downregulation.

Authors:  Jyun-Ni Chi; Jhih-Yu Yang; Chia-Hsin Hsueh; Ching-Yi Tsai; Huai-Chia Chuang; Tse-Hua Tan
Journal:  Theranostics       Date:  2022-07-18       Impact factor: 11.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.